These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 1812289

  • 1. Cellular components of proliferative vitreoretinal membranes.
    Kwak SI, Chung H, Lee J.
    Korean J Ophthalmol; 1991 Dec; 5(2):68-75. PubMed ID: 1812289
    [Abstract] [Full Text] [Related]

  • 2. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases.
    Robbins SG, Mixon RN, Wilson DJ, Hart CE, Robertson JE, Westra I, Planck SR, Rosenbaum JT.
    Invest Ophthalmol Vis Sci; 1994 Sep; 35(10):3649-63. PubMed ID: 8088954
    [Abstract] [Full Text] [Related]

  • 3. Tenascin and decorin in epiretinal membranes of proliferative vitreoretinopathy and proliferative diabetic retinopathy.
    Hagedorn M, Esser P, Wiedemann P, Heimann K.
    Ger J Ophthalmol; 1993 Feb; 2(1):28-31. PubMed ID: 7679595
    [Abstract] [Full Text] [Related]

  • 4. Proliferative activity in epiretinal membranes. The use of the monoclonal antibody Ki-67 in proliferative vitreoretinal diseases.
    Heidenkummer HP, Kampik A, Petrovski B.
    Retina; 1992 Feb; 12(1):52-8. PubMed ID: 1565872
    [Abstract] [Full Text] [Related]

  • 5. Immunolocalization of integrins in proliferative retinal membranes.
    Robbins SG, Brem RB, Wilson DJ, O'Rourke LM, Robertson JE, Westra I, Planck SR, Rosenbaum JT.
    Invest Ophthalmol Vis Sci; 1994 Aug; 35(9):3475-85. PubMed ID: 8056523
    [Abstract] [Full Text] [Related]

  • 6. [Pathomorphology of membranes appearing in proliferative vitreoretinopathies].
    Laudańska-Olszewska I, Omulecki W, Dziegielewski K, Pikulski Z, Omulecka A.
    Klin Oczna; 2006 Aug; 108(1-3):28-31. PubMed ID: 16883935
    [Abstract] [Full Text] [Related]

  • 7. Apoptosis in proliferative vitreoretinal disorders: possible involvement of TGF-beta-induced RPE cell apoptosis.
    Esser P, Heimann K, Bartz-schmidt KU, Fontana A, Schraermeyer U, Thumann G, Weller M.
    Exp Eye Res; 1997 Sep; 65(3):365-78. PubMed ID: 9299173
    [Abstract] [Full Text] [Related]

  • 8. Subretinal membranes in proliferative vitreoretinopathy. An immunohistochemical study.
    García-Arumí J, Corcostegui B, Tallada N.
    Retina; 1992 Sep; 12(3 Suppl):S55-9. PubMed ID: 1280852
    [Abstract] [Full Text] [Related]

  • 9. [Immunohistochemical study on vitrectomy specimens of proliferative retinal diseases].
    Cao J, Wu L, Zhang H.
    Zhonghua Yan Ke Za Zhi; 1997 Jul; 33(4):264-7. PubMed ID: 10451957
    [Abstract] [Full Text] [Related]

  • 10. Upregulation of RAGE and its ligands in proliferative retinal disease.
    Pachydaki SI, Tari SR, Lee SE, Ma W, Tseng JJ, Sosunov AA, Cataldergirmen G, Scarmeas N, Caspersen C, Chang S, Schiff WM, Schmidt AM, Barile GR.
    Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
    [Abstract] [Full Text] [Related]

  • 11. Glial cells in culture of preretinal membrane of proliferative vitreoretinopathy.
    Yamashita H, Hori S, Kitano S, Ishii Y, Masuda K.
    Jpn J Ophthalmol; 1985 May; 29(1):42-53. PubMed ID: 3892106
    [Abstract] [Full Text] [Related]

  • 12. Proliferative activity and immunohistochemical cell differentiation in human epiretinal membranes.
    Heidenkummer HP, Kampik A.
    Ger J Ophthalmol; 1992 May; 1(3-4):170-5. PubMed ID: 1483131
    [Abstract] [Full Text] [Related]

  • 13. Interleukin (IL)-6, interleukin (IL)-8 levels and cellular composition of the vitreous humor in proliferative diabetic retinopathy, proliferative vitreoretinopathy, and traumatic proliferative vitreoretinopathy.
    Canataroglu H, Varinli I, Ozcan AA, Canataroglu A, Doran F, Varinli S.
    Ocul Immunol Inflamm; 2005 May; 13(5):375-81. PubMed ID: 16422002
    [Abstract] [Full Text] [Related]

  • 14. [Morphological study on the intraocular proliferative membrane of proliferative diabetic retinopathy and proliferative vitreoretinopathy].
    Aoyama R.
    Nippon Ganka Gakkai Zasshi; 1990 Apr; 94(4):383-93. PubMed ID: 2396589
    [Abstract] [Full Text] [Related]

  • 15. [Comparative immunohistochemical studies of epiretinal membranes in proliferative vitreoretinal diseases].
    Heidenkummer HP, Kampik A.
    Fortschr Ophthalmol; 1991 Apr; 88(3):219-24. PubMed ID: 1889766
    [Abstract] [Full Text] [Related]

  • 16. [Contractile elements in proliferative retinal diseases].
    Molitor R, Esser P, Weller M, Wiedemann P, Heimann K.
    Ophthalmologe; 1992 Feb; 89(1):34-8. PubMed ID: 1581690
    [Abstract] [Full Text] [Related]

  • 17. Immunohistochemical study of extracellular matrix components in epiretinal membranes of vitreoproliferative retinopathy and proliferative diabetic retinopathy.
    Ioachim E, Stefaniotou M, Gorezis S, Tsanou E, Psilas K, Agnantis NJ.
    Eur J Ophthalmol; 2005 Feb; 15(3):384-91. PubMed ID: 15945009
    [Abstract] [Full Text] [Related]

  • 18. Indicators of oxidative tissue damage and inflammatory activity in epiretinal membranes of proliferative diabetic retinopathy, proliferative vitreoretinopathy and macular pucker.
    Augustin AJ, Spitznas M, Koch F, Grus F, Böker T.
    Ger J Ophthalmol; 1995 Jan; 4(1):47-51. PubMed ID: 7728110
    [Abstract] [Full Text] [Related]

  • 19. HLA antigens and lymphocytes in proliferative vitreoretinopathy.
    Proença R, Carvalho M, Proença D, Verissimo J, Regadas I, Travassos A.
    Graefes Arch Clin Exp Ophthalmol; 1994 Jan; 232(1):25-32. PubMed ID: 8119598
    [Abstract] [Full Text] [Related]

  • 20. Growth factors in vitreous and subretinal fluid cells from patients with proliferative vitreoretinopathy.
    Baudouin C, Fredj-Reygrobellet D, Brignole F, Nègre F, Lapalus P, Gastaud P.
    Ophthalmic Res; 1993 Jan; 25(1):52-9. PubMed ID: 8446368
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.